NCT03005951

Brief Summary

The purpose of this study is to see what effect skipping breakfast versus consuming breakfast has on cognitive performance and the hormones responsible for glucose homeostasis in lean and obese adolescent males. The subjects will be tested on their ability to maintain attention when given several tasks called continuous temporal expectancy tasks (CTET) and electrophysiological signals using electroencephalogram (EEG) will be monitored. These two study groups will be randomized to one of two orders: (A,B) or (B,A) where A = breakfast intervention and B = no breakfast. There will be a washout period of 7 days in between study visits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2016

Completed
6 months until next milestone

First Posted

Study publicly available on registry

December 30, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

August 30, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

1.3 years

First QC Date

June 24, 2016

Last Update Submit

August 23, 2023

Conditions

Outcome Measures

Primary Outcomes (7)

  • The measurement of glucose will be euglycemic during the breakfast study visit

    Area under the curve of glucose from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

  • The measurement of C-peptide will be steady during the breakfast study visit

    Area under the curve of C-peptide from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

  • The measurement of insulin will be steady during the breakfast study visit

    Area under the curve of insulin from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

  • The measurement of free fatty acids will be steady during the breakfast study visit

    Area under the curve of free fatty acids from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

  • The measurement of glucagon-like peptide will be steady during the breakfast study visit

    Area under the curve of glucagon- like peptide from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

  • The measurement of glucagon will be steady during the breakfast study visit

    Area under the curve of glucagon from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

  • The measurement of CTET will be better during the breakfast study visit

    Area under the curve of CTET from time 0min to 420 min.

    0min to 420 min during both during the treatment and control visits over the one year study period. Each study visit will be conducted on 2 separate days with a washout period of at least 1 week in between the study visits for each patient

Study Arms (2)

Lean males

EXPERIMENTAL

This is a randomized, two-period, cross over design with the intervention of consuming breakfast versus fasting for breakfast to study the effects on hormone responses and cognitive function using CTET in lean and obese male adolescents. These two study groups will be randomized to one of two orders:: (A,B) or (B,A) where A = Yes breakfast and B=No breakfast

Other: A= Yes BreakfastOther: B=No Breakfast

Obese males

EXPERIMENTAL

This is a randomized, two-period, cross over design with the intervention of consuming breakfast versus fasting for breakfast to study the effects on hormone responses and cognitive function using CTET in lean and obese male adolescents. These two study groups will be randomized to one of two orders:: (A,B) or (B,A) where A = Yes breakfast and B=No breakfast

Other: A= Yes BreakfastOther: B=No Breakfast

Interventions

Study visit will include analysis of cognitive function (CTET), insulin, glucagon, C-peptide, free fatty acids, and GLP-1 when given breakfast and lunch

Lean malesObese males

Study visit will include analysis of cognitive function (CTET), insulin, glucagon, C-peptide, free fatty acids, and GLP-1 when breakfast is skipped and lunch is provided.

Lean malesObese males

Eligibility Criteria

Age13 Years - 18 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Healthy males
  • No history of neurological or psychiatric illness, including major depressive disorder and attention deficit disorder.
  • Normal or corrected vision using the Snellen chart
  • Normal hearing
  • BMI greater than or equal to 95th percentile according to the Center for Disease Control and Prevention (CDC) growth charts
  • HbA1C less than or equal to 5.6%
  • Hemoglobin level of greater or equal to 12g/dL

You may not qualify if:

  • History of chronic illness and chronic use of medications that affect cognitive or glucose metabolism
  • History of substance, nicotine or alcohol dependence as assessed by CRAFFT (CAR, RELAX, ALONE, FORGET, FRIENDS, TROUBLE) questionnaire
  • History of eating disorder as assessed by the SCOFF questionnaire.
  • Developmental delay
  • Hearing and vision problems as assessed by the Snellen chart
  • Previous history of bariatric surgery
  • Currently taking supplements or medications indicated for weight loss
  • Previous history of head injury associated with loss of consciousness for several minutes
  • History of Epilepsy
  • Allergy to any of the foods used for the test breakfasts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montefiore Medical Center of Albert Einstein College of Medicine

The Bronx, New York, 10467, United States

Location

Related Publications (1)

  • Jakubowicz D, Wainstein J, Ahren B, Landau Z, Bar-Dayan Y, Froy O. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial. Diabetes Care. 2015 Oct;38(10):1820-6. doi: 10.2337/dc15-0761. Epub 2015 Jul 28.

    PMID: 26220945BACKGROUND

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Lisa Underland, MD

    Albert Einstein College of Medicine Montefiore Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2016

First Posted

December 30, 2016

Study Start

August 30, 2017

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

August 24, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations